_id
690db39eccc777a4e85d0cf7
Ticker
AVIR
Name
Atea Pharmaceuticals Inc
Exchange
NASDAQ
Address
225 Franklin Street, Boston, MA, United States, 02110
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://ateapharma.com
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Last Close
3.38
Volume
69424
Current Price
3.46
Change
0.06
Last Updated
2026-01-20T16:01:08.397Z
Image
data:image/webp;base64,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
Ipo Date
2020-10-30T00:00:00.000Z
Market Cap
265631120
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9425
Sentiment Sources
4
Rating
3.3333
Target Price
7.6667
Strong Buy
1
Buy
0
Hold
1
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
45567000
Operating Income
-45567000
Interest Expense
-
Pretax Income
-41853000
Net Income
-42049000
Eps
-0.5319146648426556
Dividends Per Share
-
Shares Outstanding
78126796
Income Tax Expense
196000
EBITDA
-41749000
Operating Margin
-
Total Other Income Expense Net
3714000
Cash
77344000
Short Term Investments
251965000
Receivables
-
Inventories
-
Total Current Assets
336138000
Property Plant Equipment
1350000
Total Assets
342963000
Payables
3515000
Short Term Debt
832000
Long Term Debt
-
Total Liabilities
27183000
Equity
315780000
Bs_currency_symbol
USD
Depreciation
104000
Change In Working Capital
-1872000
Cash From Operations
-40375000
Capital Expenditures
0
Cash From Investing
41303000
Cash From Financing
-11305000
Net Change In Cash
-10377000
Cf_currency_symbol
USD
PE
-
PB
0.8661740858825765
ROE
-13.315916144150991
ROA
-12.260506235366497
FCF
-40375000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
45567000
Quarters > 0 > income Statement > operating Income
-45567000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-41853000
Quarters > 0 > income Statement > net Income
-42049000
Quarters > 0 > income Statement > eps
-0.5319146648426556
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
79052154
Quarters > 0 > income Statement > income Tax Expense
196000
Quarters > 0 > income Statement > EBITDA
-41749000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3714000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
77344000
Quarters > 0 > balance Sheet > short Term Investments
251965000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
336138000
Quarters > 0 > balance Sheet > property Plant Equipment
1350000
Quarters > 0 > balance Sheet > total Assets
342963000
Quarters > 0 > balance Sheet > payables
3515000
Quarters > 0 > balance Sheet > short Term Debt
832000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
27183000
Quarters > 0 > balance Sheet > equity
315780000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-42049000
Quarters > 0 > cash Flow > depreciation
104000
Quarters > 0 > cash Flow > change In Working Capital
-1872000
Quarters > 0 > cash Flow > cash From Operations
-40375000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
41303000
Quarters > 0 > cash Flow > cash From Financing
-11305000
Quarters > 0 > cash Flow > net Change In Cash
-10377000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.5319146648426556
Quarters > 0 > ratios > PB
0.8661740858825765
Quarters > 0 > ratios > ROE
-13.315916144150991
Quarters > 0 > ratios > ROA
-12.260506235366497
Quarters > 0 > ratios > FCF
-40375000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
2419000
Quarters > 1 > income Statement > gross Profit
-2419000
Quarters > 1 > income Statement > operating Expenses
38926000
Quarters > 1 > income Statement > operating Income
-41345000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-36954000
Quarters > 1 > income Statement > net Income
-37161000
Quarters > 1 > income Statement > eps
-0.443727552643914
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
83747335
Quarters > 1 > income Statement > income Tax Expense
207000
Quarters > 1 > income Statement > EBITDA
-41319000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
4391000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
87721000
Quarters > 1 > balance Sheet > short Term Investments
291992000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
385604000
Quarters > 1 > balance Sheet > property Plant Equipment
1607000
Quarters > 1 > balance Sheet > total Assets
391605000
Quarters > 1 > balance Sheet > payables
8844000
Quarters > 1 > balance Sheet > short Term Debt
821000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
27189000
Quarters > 1 > balance Sheet > equity
364416000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-37161000
Quarters > 1 > cash Flow > depreciation
104000
Quarters > 1 > cash Flow > change In Working Capital
841000
Quarters > 1 > cash Flow > cash From Operations
-32870000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
15290000
Quarters > 1 > cash Flow > cash From Financing
-14093000
Quarters > 1 > cash Flow > net Change In Cash
-31673000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.443727552643914
Quarters > 1 > ratios > PB
0.7951510885910608
Quarters > 1 > ratios > ROE
-10.197411749209696
Quarters > 1 > ratios > ROA
-9.489408970774122
Quarters > 1 > ratios > FCF
-32870000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
3440000
Quarters > 2 > income Statement > gross Profit
-3440000
Quarters > 2 > income Statement > operating Expenses
35601000
Quarters > 2 > income Statement > operating Income
-39041000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-34069000
Quarters > 2 > income Statement > net Income
-34272000
Quarters > 2 > income Statement > eps
-0.40244598666869486
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
85159254
Quarters > 2 > income Statement > income Tax Expense
203000
Quarters > 2 > income Statement > EBITDA
-38937000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4972000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
119394000
Quarters > 2 > balance Sheet > short Term Investments
306042000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
433708000
Quarters > 2 > balance Sheet > property Plant Equipment
1862000
Quarters > 2 > balance Sheet > total Assets
439964000
Quarters > 2 > balance Sheet > payables
7387000
Quarters > 2 > balance Sheet > short Term Debt
811000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
28880000
Quarters > 2 > balance Sheet > equity
411084000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-34272000
Quarters > 2 > cash Flow > depreciation
104000
Quarters > 2 > cash Flow > change In Working Capital
-1606000
Quarters > 2 > cash Flow > cash From Operations
-30563000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
85608000
Quarters > 2 > cash Flow > cash From Financing
-347000
Quarters > 2 > cash Flow > net Change In Cash
54698000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.40244598666869486
Quarters > 2 > ratios > PB
0.7167659622850804
Quarters > 2 > ratios > ROE
-8.336982222611438
Quarters > 2 > ratios > ROA
-7.789728250493222
Quarters > 2 > ratios > FCF
-30563000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
416000
Quarters > 3 > income Statement > cost Of Revenue
104000
Quarters > 3 > income Statement > gross Profit
-104000
Quarters > 3 > income Statement > operating Expenses
38922000
Quarters > 3 > income Statement > operating Income
-39026000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-33317999
Quarters > 3 > income Statement > net Income
-33543000
Quarters > 3 > income Statement > eps
-0.3971321947977281
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
84463059
Quarters > 3 > income Statement > income Tax Expense
225000
Quarters > 3 > income Statement > EBITDA
-33214000
Quarters > 3 > income Statement > operating Margin
-9381.25
Quarters > 3 > income Statement > total Other Income Expense Net
5708000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
64696000
Quarters > 3 > balance Sheet > short Term Investments
390025000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
462355000
Quarters > 3 > balance Sheet > property Plant Equipment
2116000
Quarters > 3 > balance Sheet > total Assets
464668000
Quarters > 3 > balance Sheet > payables
4458000
Quarters > 3 > balance Sheet > short Term Debt
800000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
25801000
Quarters > 3 > balance Sheet > equity
438867000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-33543000
Quarters > 3 > cash Flow > depreciation
104000
Quarters > 3 > cash Flow > change In Working Capital
-8542000
Quarters > 3 > cash Flow > cash From Operations
-30397000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-3370000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-33767000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.3971321947977281
Quarters > 3 > ratios > PB
0.6659014784433552
Quarters > 3 > ratios > ROE
-7.643090047782129
Quarters > 3 > ratios > ROA
-7.218702385359009
Quarters > 3 > ratios > FCF
-30397000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-73.06971153846153
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
83367000
Annuals > 0 > income Statement > gross Profit
-83367000
Annuals > 0 > income Statement > operating Expenses
109583000
Annuals > 0 > income Statement > operating Income
-192950000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-167460000
Annuals > 0 > income Statement > net Income
-168385000
Annuals > 0 > income Statement > eps
-1.998285996695058
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
84264715
Annuals > 0 > income Statement > income Tax Expense
925000
Annuals > 0 > income Statement > EBITDA
-131800000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
25490000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
64696000
Annuals > 0 > balance Sheet > short Term Investments
390025000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
462355000
Annuals > 0 > balance Sheet > property Plant Equipment
2116000
Annuals > 0 > balance Sheet > total Assets
464668000
Annuals > 0 > balance Sheet > payables
4458000
Annuals > 0 > balance Sheet > short Term Debt
800000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
25801000
Annuals > 0 > balance Sheet > equity
438867000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-168385000
Annuals > 0 > cash Flow > depreciation
416000
Annuals > 0 > cash Flow > change In Working Capital
-7476000
Annuals > 0 > cash Flow > cash From Operations
-135499000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
56105000
Annuals > 0 > cash Flow > cash From Financing
267000
Annuals > 0 > cash Flow > net Change In Cash
-79127000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.998285996695058
Annuals > 0 > ratios > PB
0.6643377467433186
Annuals > 0 > ratios > ROE
-38.36811608072605
Annuals > 0 > ratios > ROA
-36.237700896123684
Annuals > 0 > ratios > FCF
-135499000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
70090000
Annuals > 1 > income Statement > gross Profit
-70090000
Annuals > 1 > income Statement > operating Expenses
94072000
Annuals > 1 > income Statement > operating Income
-164162000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-134938000
Annuals > 1 > income Statement > net Income
-135956000
Annuals > 1 > income Statement > eps
-1.6303682407010454
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
83389750
Annuals > 1 > income Statement > income Tax Expense
1018000
Annuals > 1 > income Statement > EBITDA
-119593000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
29224000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
143823000
Annuals > 1 > balance Sheet > short Term Investments
434283000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
590455000
Annuals > 1 > balance Sheet > property Plant Equipment
3117000
Annuals > 1 > balance Sheet > total Assets
594968000
Annuals > 1 > balance Sheet > payables
4252000
Annuals > 1 > balance Sheet > short Term Debt
760000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
39776000
Annuals > 1 > balance Sheet > equity
555192000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-135956000
Annuals > 1 > cash Flow > depreciation
416000
Annuals > 1 > cash Flow > change In Working Capital
16163000
Annuals > 1 > cash Flow > cash From Operations
-85395000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
40303000
Annuals > 1 > cash Flow > cash From Financing
257000
Annuals > 1 > cash Flow > net Change In Cash
-44835000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.6303682407010454
Annuals > 1 > ratios > PB
0.5196914490842808
Annuals > 1 > ratios > ROE
-24.48810501592242
Annuals > 1 > ratios > ROA
-22.85097685925966
Annuals > 1 > ratios > FCF
-85395000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
192180000
Annuals > 2 > income Statement > cost Of Revenue
260000
Annuals > 2 > income Statement > gross Profit
-260000
Annuals > 2 > income Statement > operating Expenses
130650000
Annuals > 2 > income Statement > operating Income
-130650000
Annuals > 2 > income Statement > interest Expense
11151000
Annuals > 2 > income Statement > pretax Income
-119499000
Annuals > 2 > income Statement > net Income
-115909000
Annuals > 2 > income Statement > eps
-1.3923774873526022
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
83245385
Annuals > 2 > income Statement > income Tax Expense
-3590000
Annuals > 2 > income Statement > EBITDA
-130390000
Annuals > 2 > income Statement > operating Margin
-67.98314080549484
Annuals > 2 > income Statement > total Other Income Expense Net
11151000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
646709000
Annuals > 2 > balance Sheet > short Term Investments
458249000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
660922000
Annuals > 2 > balance Sheet > property Plant Equipment
4094000
Annuals > 2 > balance Sheet > total Assets
666708000
Annuals > 2 > balance Sheet > payables
2551000
Annuals > 2 > balance Sheet > short Term Debt
721000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
26136000
Annuals > 2 > balance Sheet > equity
640572000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-115909000
Annuals > 2 > cash Flow > depreciation
260000
Annuals > 2 > cash Flow > change In Working Capital
-46586000
Annuals > 2 > cash Flow > cash From Operations
-120982000
Annuals > 2 > cash Flow > capital Expenditures
1943000
Annuals > 2 > cash Flow > cash From Investing
-455410000
Annuals > 2 > cash Flow > cash From Financing
370000
Annuals > 2 > cash Flow > net Change In Cash
-576022000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.3923774873526022
Annuals > 2 > ratios > PB
0.44964349378368085
Annuals > 2 > ratios > ROE
-18.094609193033726
Annuals > 2 > ratios > ROA
-17.385272113128984
Annuals > 2 > ratios > FCF
-122925000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.6396347174523884
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
351367000
Annuals > 3 > income Statement > cost Of Revenue
29000
Annuals > 3 > income Statement > gross Profit
351367000
Annuals > 3 > income Statement > operating Expenses
212990000
Annuals > 3 > income Statement > operating Income
138377000
Annuals > 3 > income Statement > interest Expense
242000
Annuals > 3 > income Statement > pretax Income
138590000
Annuals > 3 > income Statement > net Income
121190000
Annuals > 3 > income Statement > eps
1.373269570142375
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
88249243
Annuals > 3 > income Statement > income Tax Expense
17400000
Annuals > 3 > income Statement > EBITDA
138406000
Annuals > 3 > income Statement > operating Margin
39.38246904234035
Annuals > 3 > income Statement > total Other Income Expense Net
213000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
764375000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
772403000
Annuals > 3 > balance Sheet > property Plant Equipment
184000
Annuals > 3 > balance Sheet > total Assets
772892000
Annuals > 3 > balance Sheet > payables
4534000
Annuals > 3 > balance Sheet > short Term Debt
197000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
62815000
Annuals > 3 > balance Sheet > equity
710077000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
121190000
Annuals > 3 > cash Flow > depreciation
29000
Annuals > 3 > cash Flow > change In Working Capital
-247845000
Annuals > 3 > cash Flow > cash From Operations
-87005000
Annuals > 3 > cash Flow > capital Expenditures
4000
Annuals > 3 > cash Flow > cash From Investing
-4000
Annuals > 3 > cash Flow > cash From Financing
1465000
Annuals > 3 > cash Flow > net Change In Cash
-85544000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.373269570142375
Annuals > 3 > ratios > PB
0.4300130560206851
Annuals > 3 > ratios > ROE
17.067163138645526
Annuals > 3 > ratios > ROA
15.680069142907419
Annuals > 3 > ratios > FCF
-87009000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.24762997094206343
Annuals > 3 > health Score
71
Valuation > metrics > PE
-0.5319146648426556
Valuation > metrics > PB
0.8661740858825765
Valuation > final Score
70
Valuation > verdict
13.4% Undervalued
Profitability > metrics > ROE
-13.315916144150991
Profitability > metrics > ROA
-12.509445525349708
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08608208246247387
Risk > metrics > Interest Coverage
-438.1442307692308
Risk > final Score
-1693
Risk > verdict
High
Liquidity > metrics > Current Ratio
77.32643202208419
Liquidity > metrics > Quick Ratio
77.32643202208419
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
22
Prev Risks > 1
28
Prev Risks > 2
-1441
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:26:28.492Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.53
Earnings History > 0 > eps Estimate
-0.42
Earnings History > 0 > eps Difference
-0.11
Earnings History > 0 > surprise Percent
-26.1905
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.44
Earnings History > 1 > eps Estimate
-0.41
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-7.3171
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.4
Earnings History > 2 > eps Estimate
-0.41
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
2.439
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.4
Earnings History > 3 > eps Estimate
-0.2896
Earnings History > 3 > eps Difference
-0.1104
Earnings History > 3 > surprise Percent
-38.1215
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.37
Earnings History > 4 > eps Estimate
-0.49
Earnings History > 4 > eps Difference
0.12
Earnings History > 4 > surprise Percent
24.4898
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-07
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.48
Earnings History > 5 > eps Estimate
-0.76
Earnings History > 5 > eps Difference
0.28
Earnings History > 5 > surprise Percent
36.8421
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.75
Earnings History > 6 > eps Estimate
-0.61
Earnings History > 6 > eps Difference
-0.14
Earnings History > 6 > surprise Percent
-22.9508
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.47
Earnings History > 7 > eps Estimate
-0.5
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
6
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.48
Earnings History > 8 > eps Difference
0.08
Earnings History > 8 > surprise Percent
16.6667
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.34
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
0.13
Earnings History > 9 > surprise Percent
27.6596
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-08
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.43
Earnings History > 10 > eps Estimate
-0.48
Earnings History > 10 > eps Difference
0.05
Earnings History > 10 > surprise Percent
10.4167
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.41
Earnings History > 11 > eps Estimate
-0.45
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
8.8889
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-07
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.1
Earnings History > 12 > eps Estimate
-0.44
Earnings History > 12 > eps Difference
0.34
Earnings History > 12 > surprise Percent
77.2727
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.38
Earnings History > 13 > eps Estimate
-0.52
Earnings History > 13 > eps Difference
0.14
Earnings History > 13 > surprise Percent
26.9231
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.51
Earnings History > 14 > eps Estimate
-0.58
Earnings History > 14 > eps Difference
0.07
Earnings History > 14 > surprise Percent
12.069
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-28
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
1.34
Earnings History > 15 > eps Estimate
0.17
Earnings History > 15 > eps Difference
1.17
Earnings History > 15 > surprise Percent
688.2353
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-11
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.34
Earnings History > 16 > eps Estimate
-0.05
Earnings History > 16 > eps Difference
-0.29
Earnings History > 16 > surprise Percent
-580
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.02
Earnings History > 17 > eps Estimate
0.01
Earnings History > 17 > eps Difference
0.01
Earnings History > 17 > surprise Percent
100
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.34
Earnings History > 18 > eps Estimate
-0.05
Earnings History > 18 > eps Difference
0.39
Earnings History > 18 > surprise Percent
780
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-30
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.96
Earnings History > 19 > eps Estimate
0.16
Earnings History > 19 > eps Difference
0.8
Earnings History > 19 > surprise Percent
500
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.74
Earnings History > 20 > eps Estimate
-1.05
Earnings History > 20 > eps Difference
-0.69
Earnings History > 20 > surprise Percent
-65.7143
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-02
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.16
Earnings History > 21 > eps Estimate
-0.16
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-19
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.03
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.03
Earnings History > 22 > surprise Percent
-
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGrowth Report: What is Potbelly Corporations book value per share - Weekly Stock Summary & Expert Approved Trade Ideas baoquankhu1.vn
Read more →Moving Averages: Can Amcor plc stock outperform in a bear market - Analyst Upgrade & Free Technical Confirmation Trade Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$7.6667
Analyst Picks
Strong Buy
1
Buy
0
Hold
1
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 78.35% of the total shares of Atea Pharmaceuticals Inc
1.
BlackRock Inc(10.9234%)
since
2025/06/30
2.
BML Capital Management LLC(9.5893%)
since
2025/06/30
3.
FMR Inc(7.2076%)
since
2025/06/30
4.
TANG CAPITAL MANAGEMENT LLC(6.161%)
since
2025/06/30
5.
Vanguard Group Inc(6.1585%)
since
2025/06/30
6.
Fidelity Growth Compy Commingled Pl S(4.868%)
since
2025/07/31
7.
Bain Capital Life Sciences Investors, LLC(3.1322%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.9939%)
since
2025/07/31
9.
Geode Capital Management, LLC(2.4265%)
since
2025/06/30
10.
iShares Russell 2000 ETF(2.2604%)
since
2025/08/31
11.
State Street Corp(2.2385%)
since
2025/06/30
12.
Dimensional Fund Advisors, Inc.(1.7784%)
since
2025/06/30
13.
Renaissance Technologies Corp(1.5551%)
since
2025/06/30
14.
Fidelity Growth Company Fund(1.1822%)
since
2025/07/31
15.
Vanguard Institutional Extnd Mkt Idx Tr(1.1163%)
since
2025/07/31
16.
Fidelity Small Cap Index(0.9529%)
since
2025/06/30
17.
Two Sigma Advisers, LLC(0.8832%)
since
2025/06/30
18.
Northern Trust Corp(0.8512%)
since
2025/06/30
19.
Fidelity Growth Company K6(0.8458%)
since
2025/07/31
20.
BlackRock Advantage Small Cap Core Instl(0.8388%)
since
2025/07/31
21.
iShares Russell 2000 Value ETF(0.8355%)
since
2025/08/31
22.
JPMorgan Chase & Co(0.8224%)
since
2025/06/30
23.
Charles Schwab Investment Management Inc(0.8005%)
since
2025/06/30
24.
Newtyn Management LLC(0.7309%)
since
2025/06/30
25.
Morgan Stanley - Brokerage Accounts(0.6858%)
since
2025/06/30
26.
CM Management, LLC(0.6301%)
since
2025/06/30
27.
Peapod Lane Capital LLC(0.5702%)
since
2025/06/30
28.
Almitas Capital LLC(0.5612%)
since
2025/06/30
29.
iShares Biotechnology ETF(0.5243%)
since
2025/08/31
30.
Fidelity Extended Market Index(0.5107%)
since
2025/07/31
31.
Two Sigma Investments LLC(0.462%)
since
2025/06/30
32.
Vanguard Russell 2000 ETF(0.4591%)
since
2025/07/31
33.
Schwab US Small-Cap ETF™(0.4542%)
since
2025/08/30
34.
DFA US Targeted Value I(0.4512%)
since
2025/07/31
35.
Dimensional US Targeted Value ETF(0.3846%)
since
2025/08/29
36.
State St Russell Sm Cap® Indx SL Cl I(0.3772%)
since
2025/08/31
37.
Vanguard Strategic Equity Inv(0.3508%)
since
2025/06/30
38.
SQUAD Aguja Opportunities I(0.3024%)
since
2025/05/31
39.
Schwab Small Cap Index(0.2432%)
since
2025/07/31
40.
NT R2000 Index Fund - NL(0.2335%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.53
EPS Estimate
-0.42
EPS Difference
-0.11
Surprise Percent
-26.1905%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.